1,269
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Diacerein-Loaded novel gastroretentive nanofiber system using PLLA: Development and in vitro characterization

, , &
Pages 928-936 | Received 14 Nov 2014, Accepted 12 Dec 2014, Published online: 31 Mar 2015

References

  • Baji A, Mai Y-W, Wong S-C, Abtahi M, Chen P. 2010. Electrospinning of polymer nanofibers: Effects on oriented morphology, structures and tensile properties. Compos Sci Technol. 70:703–718.
  • Chaudhary S, Garg T, Murthy RS, Rath G, Goyal AK. 2014. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target. 1–12.
  • Chew SY, Hufnagel TC, Lim CT, Leong KW. 2006. Mechanical properties of single electrospun drug-encapsulated nanofibres. Nanotechnology. 17:3880.
  • Gagandeep, Garg T, Malik B, Rath G, Goyal AK. 2014b. Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci. 53:10–16.
  • Garg R, Gupta G. 2008. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res. 7:1055–1066.
  • Garg T. 2014. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. 1–8.
  • Garg T, Goyal AK. 2012. Iontophoresis: drug delivery system by applying an electrical potential across the skin. Drug Deliv Lett. 2:270–280.
  • Garg T, Goyal AK. 2014a. Biomaterial-based scaffolds–current status and future directions. Expert Opin Drug Deliv. 11:767–789.
  • Garg T, Goyal AK. 2014b. Liposomes: targeted and controlled delivery system. Drug Deliv Lett. 4:62–71.
  • Garg T, Goyal AK, Arora S, Murthy R. 2012a. Development, optimization & evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of type-2 diabetes mellitus. Drug Deliv Lett. 2:251–261.
  • Garg T, Kumar A, Rath G, Goyal AK. 2014a. Gastroretentive drug delivery systems for therapeutic management of peptic ulcer. Crit Rev Ther Drug Carrier Syst. 31:531–557.
  • Garg T, Rath G, Goyal AK. 2014b. Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease-psoriasis. Crit Rev Ther Drug Carrier Syst. 31:331–364.
  • Garg T, Rath G, Goyal AK. 2014c. Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv.
  • Garg T, Singh O, Arora S, Murthy R. 2011a. Dendrimer—A novel scaffold for drug delivery. Int J Pharm Sci Rev Res. 7:211–220.
  • Garg T, Singh O, Arora S, Murthy R. 2011b. Patented microencapsulation techniques and its application. J Pharm Res. 4:2097–2102.
  • Garg T, Singh O, Arora S, Murthy R. 2012b. Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst. 29:1–63.
  • Garg T, Singh S, Goyal AK. 2013. Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst. 30:369–409.
  • Goyal AK, Rath G, Garg T. 2013a. Nanotechnological approaches for genetic immunization. DNA and RNA Nanobiotechnologies In Medicine: Diagnosis And Treatment Of Diseases. Erdmann, Volker A., Barciszewski, hab. Jan (Eds.). Springer-Verlag Berlin Heidelberg, pp. 67–120.
  • Goyal G, Garg T, Malik B, Chauhan G, Rath G, Goyal AK. 2013b. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv.
  • Goyal G, Garg T, Rath G, Goyal AK. 2014a. Current nanotechnological strategies for an effective delivery of drugs in treatment of periodontal disease. Crit Rev Ther Drug Carrier Syst. 31:89–119.
  • Goyal G, Garg T, Rath G, Goyal AK. 2014b. Current nanotechnological strategies for treating glaucoma. Crit Rev Ther Drug Carrier Syst. 31:365–405.
  • Grainger SJ, El-Sayed MEH. 2010. Stimuli-Sensitive particles for drug delivery. In: Jabbari E, Khademhosseini A, Eds. Biologically-Responsive Hybrid Biomaterials. Singapore: World Scientific, pp. 171–190.
  • Hussain T, Garg T, Goyal AK, Rath G. 2014. Biomedical Applications of Nanofiber Scaffolds in Tissue Engineering. J Biomater Tiss Eng. 4:600–623.
  • Jaimini M, Rana A, Tanwar Y. 2007. Formulation and evaluation of famotidine floating tablets. Curr Drug Deliv. 4:51–55.
  • Johal HS, Garg T, Rath G, Goyal AK. 2014. Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv. 1–14.
  • Joshi D, Garg T, Goyal AK, Rath G. 2014. Advanced drug delivery approaches against periodontitis. Drug Deliv. 1–15.
  • Kalia V, Garg T, Rath G, Goyal AK. 2014. Development and evaluation of a sublingual film of the antiemetic granisetron hydrochloride. Artif Cells Nanomed Biotechnol. 1–5.
  • Kataria K, Sharma A, Garg T, Goyal AK, Rath G. 2014. Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett. 4:79–86.
  • Kaur M, Garg T, Narang RK. 2014a. A review of emerging trends in the treatment of tuberculosis. Artif Cells Nanomed Biotechnol. 1–7.
  • Kaur M, Garg T, Rath G, Goyal AK. 2014b. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst. 31: 49–88.
  • Kaur M, Malik B, Garg T, Rath G, Goyal AK. 2014c. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv.
  • Kaur N, Garg T, Goyal AK, Rath G. 2014d. Formulation, optimization and evaluation of curcumin-beta-cyclodextrin-loaded sponge for effective drug delivery in thermal burns chemotherapy. Drug Deliv. 1–10.
  • Kaur P, Garg T, Rath G, Murthy RS, Goyal AK. 2014e. Surfactant-based drug delivery systems for treating drug-resistant lung cancer. Drug Deliv. 1–12.
  • Kaur R, Garg T, Das Gupta U, Gupta P, Rath G, Goyal AK. 2014f. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol. 1–6.
  • Kaur R, Garg T, Rath G, Goyal AK. 2014g. Advanced aerosol delivery devices for potential cure of acute and chronic diseases. Crit Rev Ther Drug Carrier Syst. 31:495–530.
  • Kaur V, Garg T, Rath G, Goyal AK. 2014h. Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J Drug Target. 22:859–870.
  • Malik R, Garg T, Goyal AK, Rath G. 2014. Polymeric nanofibers: targeted gastro-retentive drug delivery systems. J Drug Target. 23:109–124.
  • Marwah H, Garg T, Goyal AK, Rath G. 2014. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 1–15.
  • Meng Z, Xu X, Zheng W, Zhou H, Li L, Zheng Y, Lou X. 2011. Preparation and characterization of electrospun PLGA/gelatin nanofibers as a potential drug delivery system. Colloids Surf B Biointerfaces. 84:97–102.
  • Modgill V, Garg T, Goyal AK, Rath G. 2014. Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes. Artif Cells Nanomed Biotechnol. 1–6.
  • Morie A, Garg T, Goyal AK, Rath G. 2014. Nanofibers as novel drug carrier – an overview. Artif Cells Nanomed Biotechnol. 1–9.
  • Pabreja S, Garg T, Rath G, Goyal AK. 2014. Mucosal vaccination against tuberculosis using Ag85A-loaded immunostimulating complexes. Artif Cells Nanomed Biotechnol. 1–8.
  • Pillay V, Dott C, Choonara YE, Tyagi C, Tomar L, Kumar P, et al. 2013. A review of the effect of processing variables on the fabrication of electrospun nanofibers for drug delivery applications. J Nanomater.
  • Rohilla R, Garg T, Bariwal J, Goyal AK, Rath G. 2014a. Development, optimization and characterization of glycyrrhetinic acid-chitosan nanoparticles of atorvastatin for liver targeting. Drug Deliv. 1–8.
  • Rohilla R, Garg T, Goyal AK, Rath G. 2014b. Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Deliv. 1–17.
  • Semalty M, Semalty A, Kumar G. 2008. Formulation and characterization of mucoadhesive buccal films of glipizide. Indian J Pharm Sci. 70:43–48.
  • Sharma A, Garg T, Aman A, Panchal K, Sharma R, Kumar S, Markandeywar T. 2014a. Nanogel-an advanced drug delivery tool: current and future. Artif Cells Nanomed Biotechnol. 1–13.
  • Sharma R, Garg T, Goyal AK, Rath G. 2014b. Development, optimization and evaluation of polymeric electrospun nanofiber: a tool for local delivery of fluconazole for management of vaginal candidiasis. Artif Cells Nanomed Biotechnol. 1–8.
  • Sharma R, Singh H, Joshi M, Sharma A, Garg T, Goyal AK, Rath G. 2014c. Recent advances in polymeric electrospun nanofibers for drug delivery. Crit Rev Ther Drug Carrier Syst. 31:187–217.
  • Singh B, Garg T, Goyal AK, Rath G. 2014a. Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol. 1–10.
  • Singh H, Sharma R, Joshi M, Garg T, Goyal AK, Rath G. 2014b. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artificial Cells Nanomed Biotechnol. 1–7.
  • Singh K, Arora N, Garg T. 2012a. RFID: a trustable security tool in pharmaceutical industry. Am J Pharm Tech Res. 2:113–127.
  • Singh K, Arora N, Garg T. 2012b. Superbug: Antimicrobial resistance due to NDM-1. IJIPLS. 2:58–66.
  • Singh O, Garg T, Rath G, Goyal AK. 2014c. Microbicides for the treatment of sexually transmitted HIV infections. J Pharmaceutics. 1–18.
  • Taepaiboon P, Rungsardthong U, Supaphol P. 2007. Vitamin-loaded electrospun cellulose acetate nanofiber mats as transdermal and dermal therapeutic agents of vitamin A acid and vitamin E. Eur J Pharm Biopharm. 67:387–397.
  • Wade A, Weller PJ. 1994. Handbook of pharmaceutical excipients, Washington: American Pharmaceutical association, London: pharmaceutical press.
  • Xu X, Yang Q, Wang Y, Yu H, Chen X, Jing X. 2006. Biodegradable electrospun poly (L-lactide) fibers containing antibacterial silver nanoparticles. Euro Polym J. 42:2081–2087.
  • Yu D-G, Zhu L-M, White K, Branford-White C. 2009a. Electrospun nanofiber-based drug delivery systems. Health. 1:67.
  • Yu D, Zhang X, Shen X, Branford-White C, Zhu LM. 2009b. [The improvement of poorly water-soluble drug solubility through electrospun drug-loaded nanofibers]. Yao Xue Xue Bao = Acta pharmaceutica Sinica. 44:1179–1182.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.